AC

Ascenta Capital

North America, New York, United States, New York

Description

Ascenta Capital is a private equity and venture capital firm.

Investor Profile

Ascenta Capital has backed more than 7 startups, with 2 new investments in the last 12 months alone. The firm has led 6 rounds, about 86% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C rounds (top funding stages).
  • Majority of deals are located in United States, Canada.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 2 rounds in the past year.

Stage Focus

  • Series B (57%)
  • Series C (43%)

Country Focus

  • United States (86%)
  • Canada (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Oncology
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Software
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ascenta Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 2
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 2
General Catalyst
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Delos Capital
North America, New York, United States, New York
Co-Investments: 2
Woodline Partners
North America, California, United States, San Francisco
Co-Investments: 2
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 2
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 2
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 2

Which angels does Ascenta Capital often collaborate with?

Shared Deals: 1
WR
North America, California, United States, La Jolla
Shared Deals: 1

What are some of recent deals done by Ascenta Capital?

Angitia Biopharmaceuticals

Westlake Village, California, United States

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

BiopharmaBiotechnologyHealth CareMedical
Series DFeb 5, 2026
Amount Raised: $130,000,000
Triana Biomedicines

Lexington, Massachusetts, United States

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series BDec 3, 2025
Amount Raised: $120,000,000
Iambic

San Diego, California, United States

Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

Artificial Intelligence (AI)Machine LearningSoftwareTherapeutics
Series UnknownNov 10, 2025
Amount Raised: $100,000,000
Tubulis

Munich, Bayern, Germany

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series COct 15, 2025
Amount Raised: $358,068,338
Alpha9 Theranostics

Vancouver, British Columbia, Canada

Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

BiotechnologyMedicalProduct Research
Series COct 23, 2024
Amount Raised: $175,000,000
OrsoBio

Palo Alto, California, United States

OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.

BiopharmaBiotechnologyHealth CareMedicalTherapeutics
Series BSep 6, 2024
Amount Raised: $67,000,000
Cardurion Pharmaceuticals

Boston, Massachusetts, United States

Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Series BJul 16, 2024
Amount Raised: $260,000,000
Odyssey Therapeutics

Cambridge, Massachusetts, United States

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

BiotechnologyHealth CareOncologyTherapeutics
Series CDec 5, 2023
Amount Raised: $101,000,000
Iambic Therapeutics

San Diego, California, United States

Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

Artificial Intelligence (AI)Machine LearningSoftwareTherapeutics
Series BOct 3, 2023
Amount Raised: $100,000,000
ADARx Pharmaceuticals

San Diego, California, United States

ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.

BiotechnologyHealth CareMedicalPharmaceutical
Series CAug 9, 2023
Amount Raised: $200,000,000

Find More Investors Like Ascenta Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Ascenta Capital | Pipeseed